Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, March 2001, p. 349-351, Vol. 8, No. 2
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.349-351.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Two Methods for Rapid Serological Diagnosis of Acute
Leptospirosis
Paul N.
Levett,1,2,*
Songee L.
Branch,2
Carol U.
Whittington,2
Charles N.
Edwards,1,3 and
Helene
Paxton4
School of Clinical Medicine & Research,
University of the West Indies, Bridgetown,1
Leptospira Laboratory, Ministry of Health, St.
Michael,2 and Department of Medicine,
Queen Elizabeth Hospital, Bridgetown,3
Barbados; and PanBio InDx Inc., Baltimore,
Maryland4
Received 21 August 2000/Returned for modification 9 November
2000/Accepted 11 December 2000
 |
ABSTRACT |
Leptospirosis is a common and underdiagnosed zoonosis. Two rapid
assays for serological diagnosis of acute leptospirosis in diagnostic
laboratories, the immunoglobulin M (IgM)-dipstick assay and the
indirect hemagglutination assay (IHA), were evaluated and compared with
standard assays. Sera were examined from 104 patients admitted to a
hospital for investigation in a leptospirosis diagnostic protocol.
Specimens for serology were taken on days 1 and 4 of the patients'
hospital stay. Antibodies were detected using an IgM-enzyme-linked
immunosorbent assay (ELISA), microscopic agglutination test (MAT), an
IgM-dipstick assay, and an IHA. Fifty-one patients were found to have
leptospirosis. The sensitivity of the IgM-dipstick assay was 98%, its
specificity was 90.6%, its positive predictive value was 90.9%, and
its negative predictive value was 98%. The sensitivity of the IHA was
92.2%, its specificity was 94.4%, its positive predictive value was
95.9%, and its negative predictive value was 92.7%. The standard
IgM-ELISA and MAT, were positive in the first samples tested from 67 and 55% of the cases, respectively, and the rapid IgM-dipstick assay
and IHA were positive in 71 and 49%, respectively, in the first sample
tested. Both rapid assays are highly sensitive and specific. Neither
requires specialized equipment, and both are suitable for use in
diagnostic laboratories.
 |
INTRODUCTION |
Leptospirosis is an acute febrile
disease, widely recognized as being emergent or reemergent (5,
13). In tropical and subtropical regions, the disease is
endemic, and exposure to infection is widespread (8, 12,
20). In temperate climates the disease is primarily one of
occupational or recreational exposure, as evidenced by a recent large
outbreak in the United States that was associated with swimming during
a triathlon (6).
Leptospirosis is frequently underdiagnosed, because of the nonspecific
symptoms early in the disease and the difficulty of performing both
culture and the reference serological test
the microscopic
agglutination test (MAT). The mortality rate in severe leptospirosis
can be as high as 15% (12); early diagnosis is essential
if antibiotic treatment is to be effective.
Detection of immunoglobulin M (IgM) antibodies by enzyme-linked
immunosorbent assay (ELISA) has been used widely (1, 19) and is more sensitive than MAT (7). Several rapid methods
for antibody detection are now available commercially, which detect genus-specific antibodies, either IgM (17, 21) or both IgG and IgM (2, 4, 14). The reported sensitivities of these assays have ranged from 87 to 100%. In this study we evaluated two of
those rapid assays, which can be used in laboratories with little
specialized equipment, the IgM-dipstick assay and the indirect hemagglutination assay (IHA).
 |
MATERIALS AND METHODS |
Specimens.
Samples were obtained from patients admitted to
the Queen Elizabeth Hospital, Bridgetown, Barbados, who had a history
and clinical manifestations suggestive of leptospirosis. The diagnostic protocol used in this study has been described previously
(14). Blood samples for serology were collected from
patients on the day of admission and on the fourth day after admission,
and for some patients a convalescent sample was also taken before
discharge from the hospital or during a follow-up visit to the
outpatient clinic. Blood cultures were made on the day of admission by
inoculating three drops of blood into 10 ml of polysorbate medium at
the patient's bedside (EMJH; Difco Laboratories). Urine from patients
who were not anuric on the fourth day of their admission was inoculated into the same medium within 1 h of collection.
ELISA.
IgG and IgM titers were determined by ELISA
(19), using Leptospira biflexa Patoc I (serovar
patoc) as antigen. An IgM titer of
160 was regarded as positive.
MAT.
Sera were examined by the MAT, using a battery of 22 serovars to establish seroconversion or a rise in titer
(7). The antigens used included both reference strains and
locally prevalent serovars of the following serogroups (serovars in
parentheses): Australis (bajan, barbadensis, and bratislava),
Autumnalis (bim and fortbragg), Ballum (arborea and ballum), Bataviae
(bataviae and brasiliensis), Canicola (canicola), Cynopteri
(cynopteri), Grippotyphosa (grippotyphosa), Icterohaemorrhagiae
(copenhageni), Mini (georgia), Panama (mangus and panama), Pomona
(pomona), Pyrogenes (pyrogenes), Tarassovi (tarassovi), Sejroe (hardjo
and sejroe), and L. biflexa Semaranga (patoc).
The diagnosis of leptospirosis was confirmed by a fourfold rise in
titer between two sera tested by the same method, an initial titer of
800 in the MAT, an IgM titer of
160 in the ELISA, a positive
culture from blood or urine, or any combination of these results.
IHA.
The IHA (MRL Diagnostics, Cypress, Calif.) was
performed as described previously (14). Fifty microliters
of a 1:50 dilution of each serum specimen was mixed with 25 µl of
either antigen-coated test cells or uncoated control cells, in the
wells of a U-bottomed microtiter tray. Plates were incubated at 25°C
for 1 h. Hemagglutination was read on a scale of 0 to ++++.
Positive and negative control sera were tested each time the test was performed.
IgM-dipstick assay.
IgM antibodies were detected using a
semiquantitative dot-ELISA dipstick assay (Integrated Diagnostics,
Baltimore, Md.). All steps were carried out at 50°C. In this assay,
10 µl of serum and 40 µl of goat antihuman IgG absorbent (proSorb
G) were diluted in 2 ml of sample diluent and incubated at 50°C for
10 min prior to addition of the assay strip. Alkaline
phosphatase-conjugated goat anti-human IgM (µ chain) was used as
described previously (3). The assay required approximately
2 h for completion. After assay strips were allowed to dry,
positive dots were gray to blue with distinct borders against a white
background. Each assay strip contained positive and negative control
dots. The test was scored on a scale of 1 to 4 dots; only strips with
two or more positive dots were recorded as positive tests. Each
positive dot represented an approximately fourfold difference in MAT titer.
 |
RESULTS |
Diagnostic samples.
Two-hundred nine specimens were examined
from 104 patients investigated using a protocol for the diagnosis of
leptospirosis. Fifty-one patients were found to have leptospirosis, and
53 did not. Diagnoses in the 53 patients without leptospirosis included dengue fever (18 cases), acute hepatitis B (3 cases), typhoid (1 case),
alcoholic hepatitis (5 cases), and obstructive jaundice (4 cases). A
variety of other noncommunicable conditions was also represented in
individual cases. Leptospires were isolated from 24 of 50 cases (48%),
while the remaining cases were confirmed by serology. The isolates were
identified as Leptospira kirschneri serovar bim,
L. interrogans serovar copenhageni, and L. borgpetersenii serovar arborea.
The IgM-dipstick assay detected 50 cases of leptospirosis; there were
five false-positive results. The sensitivity of the IgM-dipstick
for detection of acute leptospirosis cases was 98%, its specificity
was 90.6%, its positive predictive value was 90.9%, and its negative
predictive value was 98%. The IHA detected 47 cases of leptospirosis;
there were two false-positive IHA results. The sensitivity of IHA for
detection of acute leptospirosis was 92.2%, its specificity was
94.4%, its positive predictive value was 95.9%, and its negative
predictive value was 92.7%.
One-hundred three serum specimens were examined from 51 patients
diagnosed with leptospirosis. First acute (A1) samples were taken on
the day of admission to the hospital. The mean time from onset of
symptoms to the collection of the A1 sample was 6.1 days (range, 1 to
17 days). The date of onset of symptoms was unknown for six cases. The
second acute (A2) samples were taken 4 days after admission to the
hospital, and a convalescent sample was available from one patient,
taken 10 days after admission. One-hundred six specimens were examined
from 53 patients whose diagnosis was not leptospirosis.
Results on A1 samples.
The distribution of test results on A1
samples from leptospirosis patients is shown in Table
1. Seroconversion occurred as indicated
by the MAT in all patients, and the A1 sample was negative in 23 of 51 patients (45%), whose samples were taken a mean of 5.1 days after
onset. Eighteen (35%) of the A1 samples gave a MAT titer of
800;
these samples were taken a mean of 8.1 days after onset of symptoms. In
one patient, seroconversion did not occur until the convalescent
sample, which was taken 10 days after admission to the hospital. In the
remaining patients there was a fourfold rise in titer between the A1
and A2 samples, taken 4 days apart.
The IgM-dipstick assay was positive in 34 of the A1 samples (67%)
taken a mean of 6.6 days after onset and negative in 17 (33%), of
which 5 were IgM-dipstick positive and one was IHA positive. The
IgM-dipstick was positive in A1 samples from 36 of 51 patients (71%) with leptospirosis, whereas IHA was positive in 25 of 51 A1
samples (49%). The intervals between onset of symptoms and positive
and negative results in the respective tests are shown in Table
2. The sensitivity of diagnosis based on
a positive A1 sample was 35% for MAT, 67% for IgM-ELISA, 71% for the
IgM-dipstick assay, and 49% for the IHA.
 |
DISCUSSION |
The diagnosis of leptospirosis is often unconfirmed, because of a
lack of clinical suspicion, inappropriate sample collection, the
unavailability of testing facilities, or a combination of these
factors. Several rapid assays have been developed recently (2,
11, 15, 16, 18), which can be used for screening of acutely ill patients.
Both of the rapid tests evaluated in this study exhibited high
sensitivities (>92%) and specificities (>90%) for detection of
cases of severe, acute leptospirosis. The IgM-dipstick (dot-ELISA) assay was more sensitive than the IHA, and it became positive earlier
(Table 2). Assays which detect IgM are more sensitive than the MAT and
give positive results earlier in the acute phase of the disease
(7). This is important because if treatment decisions are
to be based on laboratory results, they must be made as early as
possible, often without having available the results from paired sera.
When only samples from acutely ill patients were considered, the
IgM-dipstick assay was of comparable sensitivity to the IgM-ELISA,
whereas the sensitivity of the IHA was closer to that of the MAT.
The results of this study confirm our previous findings on the utility
of the IHA in a population in which severe leptospirosis occurs at a
high incidence (14). In other populations the sensitivity of the IHA has not been as high (9, 22). However,
differences in case definition and case ascertainment may account for
some of the observed difference in sensitivity. Both the present
evaluation and our previous study (14) were performed in a
population of hospitalized patients admitted for investigation and
management of severe, acute leptospirosis. In one recent study, the
sensitivity of IHA was considerably higher in leptospirosis cases that
were hospitalized and in those from whom leptospires were isolated than
in the overall population studied (9). Moreover, similar differences in test performance were noted between these two
populations in a recent multicenter evaluation of another IgM-dipstick
assay (17).
The IgM-dipstick assay was simple to perform, and the only equipment
required was a water bath or heating block. The assay can therefore be
performed in peripheral laboratories with only rudimentary equipment.
Each assay strip contains positive and negative control dots, making
the IgM-dipstick economical for single-sample testing. In our
experience the only limitation to its use has been the relatively small
number of samples (8 to 10) that can be tested in one batch. However,
each assay was completed in approximately 2 h. If large numbers of
tests must be performed, then a conventional microtiter plate ELISA
assay can be used.
The IgM-dipstick is a semiquantitative assay, with each extra dot
representing an approximately fourfold increase in titer. Thus it is
possible to detect both seroconversion and a rising titer of IgM
antibodies. In contrast, another recently developed dipstick assay
allows only approximate estimation of staining intensity (11,
17). For assays which are intended to be used as screening
tests, this lack of quantitation is relatively unimportant.
Both of the rapid assays detected antibodies in patients infected with
all three leptospiral serovars isolated from patients in this study.
The range of serovars isolated from patients in Barbados over the past
20 years has been limited to four, including bim, copenhageni, arborea,
and L. noguchii serovar bajan/barbadensis (10).
The latter serovar has been isolated only rarely and was not recovered
in this study.
In this study we evaluated two rapid assays for early diagnosis of
acute leptospirosis in a hospital-based population. Both assays were
highly sensitive and specific. Neither required specialized equipment,
and could be performed in peripheral laboratories with relatively
little expertise. The selection of a serodiagnostic assay is dependent
on several factors, including the clinical likelihood of disease, the
anticipated workload, and the availability of confirmatory testing in
more specialized laboratories. Either of the tests studied may be
suitable for use in diagnostic laboratories for screening sera from
acutely ill patients.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Leptospira
Laboratory, Enmore #2, Lower Collymore Rock, St. Michael, Barbados.
Phone: (246) 427-5586. Fax: (246) 429-6738. E-mail:
levett{at}sunbeach.net.
 |
REFERENCES |
| 1.
|
Adler, B.,
A. M. Murphy,
S. A. Locarnini, and S. Faine.
1980.
Detection of specific anti-leptospiral immunoglobulins M and G in human serum by solid-phase enzyme-linked immunosorbent assay.
J. Clin. Microbiol.
11:452-457[Abstract/Free Full Text].
|
| 2.
|
Arimitsu, Y.,
E. Kmety,
Y. Ananyina,
G. Baranton,
I. R. Ferguson,
L. Smythe, and W. J. Terpstra.
1994.
Evaluation of the one-point microcapsule agglutination test for diagnosis of leptospirosis.
Bull. W. H. O.
72:395-399[Medline].
|
| 3.
|
Branch, S. L., and P. N. Levett.
1999.
Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus.
Clin. Diagn. Lab. Immunol.
6:555-557[Abstract/Free Full Text].
|
| 4.
|
Brandão, A. P.,
E. D. Camargo,
E. D. da Silva,
M. V. Silva, and R. V. Abrão.
1998.
Macroscopic agglutination test for rapid diagnosis of human leptospirosis.
J. Clin. Microbiol.
36:3138-3142[Abstract/Free Full Text].
|
| 5.
|
Brandling-Bennett, A. D., and F. Pinheiro.
1996.
Infectious diseases in Latin America and the Caribbean: are they really emerging and increasing?
Emerg. Infect. Dis.
2:59-61[Medline].
|
| 6.
|
Centers for Disease Control and Prevention.
1998.
Update: leptospirosis and unexplained acute febrile illness among athletes participating in triathlons Illinois and Wisconsin, 1998.
Morb. Mortal. Wkly. Rep.
47:673-676[Medline].
|
| 7.
|
Cumberland, P. C.,
C. O. R. Everard, and P. N. Levett.
1999.
Assessment of the efficacy of the IgM enzyme-linked immunosorbent assay (ELISA) and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis.
Am. J. Trop. Med. Hyg.
61:731-734[Abstract].
|
| 8.
|
Douglin, C. P.,
C. Jordan,
R. Rock,
A. Hurley, and P. N. Levett.
1997.
Risk factors for severe leptospirosis in the parish of St. Andrew, Barbados.
Emerg. Infect. Dis.
3:78-80[Medline].
|
| 9.
|
Effler, P. V.,
H. Y. Domen,
S. L. Bragg,
T. Aye, and D. M. Sasaki.
2000.
Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis in Hawaii.
J. Clin. Microbiol.
38:1081-1084[Abstract/Free Full Text].
|
| 10.
|
Everard, C. O. R.,
C. N. Edwards,
J. D. Everard, and D. G. Carrington.
1995.
A twelve year study of leptospirosis on Barbados.
Eur. J. Epidemiol.
11:311-320[CrossRef][Medline].
|
| 11.
|
Gussenhoven, G. C.,
M. A. W. G. van der Hoorn,
M. G. A. Goris,
W. J. Terpstra,
R. A. Hartskeerl,
B. W. Mol,
C. W. van Ingen, and H. L. Smits.
1997.
LEPTO dipstick, a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human sera.
J. Clin. Microbiol.
35:92-97[Abstract].
|
| 12.
|
Ko, A. I.,
M. Galvao Reis,
C. M. Ribeiro Dourado,
W. D. Johnson,
L. W. Riley, and Salvador Leptospirosis Study Group.
1999.
Urban epidemic of severe leptospirosis in Brazil.
Lancet
354:820-825[Medline].
|
| 13.
|
Levett, P. N.
1999.
Leptospirosis: re-emerging or re-discovered disease?
J. Med. Microbiol.
48:417-418[Medline].
|
| 14.
|
Levett, P. N., and C. U. Whittington.
1998.
Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis.
J. Clin. Microbiol.
36:11-14[Abstract/Free Full Text].
|
| 15.
|
Ramadass, P.,
B. Samuel, and K. Nachimuthu.
1999.
A rapid latex agglutination test for detection of leptospiral antibodies.
Vet. Microbiol.
70:137-140[CrossRef][Medline].
|
| 16.
|
Silva, M. V.,
P. M. Nakamura,
E. D. Camargo,
L. Batista,
A. J. Vaz,
E. C. Romero, and A. P. Brandão.
1997.
Immunodiagnosis of human leptospirosis by dot-ELISA for the detection of IgM, IgG, and IgA antibodies.
Am. J. Trop. Med. Hyg.
56:650-655.
|
| 17.
|
Smits, H. L.,
Y. V. Ananyina,
A. Chereshsky,
L. Dancel,
A. F. R. F. Lai,
H. D. Chee,
P. N. Levett,
T. Masuzawa,
Y. Yanagihara,
M. A. Muthusethupathi,
E. J. Sanders,
D. M. Sasaki,
H. Domen,
C. Yersin,
T. Aye,
S. L. Bragg,
G. C. Gussenhoven,
M. G. Goris,
W. J. Terpstra, and R. A. Hartskeerl.
1999.
International multicenter evaluation of the clinical utility of a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human serum specimens.
J. Clin. Microbiol.
37:2904-2909[Abstract/Free Full Text].
|
| 18.
|
Smits, H. L.,
M. A. van Der Hoorn,
M. G. Goris,
G. C. Gussenhoven,
C. Yersin,
D. M. Sasaki,
W. J. Terpstra, and R. A. Hartskeerl.
2000.
Simple latex agglutination assay for rapid serodiagnosis of human leptospirosis.
J. Clin. Microbiol.
38:1272-1275[Abstract/Free Full Text].
|
| 19.
|
Terpstra, W. J.,
G. S. Ligthart, and G. J. Schoone.
1980.
Serodiagnosis of human leptospirosis by enzyme-linked-immunosorbent-assay (ELISA).
Zentbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt.
A247:400-405.
|
| 20.
|
Trevejo, R. T.,
J. G. Rigau-Perez,
D. A. Ashford,
E. M. McClure,
C. Jarquin-Gonzalez,
J. J. Amador,
J. O. de los Reyes,
A. Gonzalez,
S. R. Zaki,
W. J. Shieh,
R. G. McLean,
R. S. Nasci,
R. S. Weyant,
C. A. Bolin,
S. L. Bragg,
B. A. Perkins, and R. A. Spiegel.
1998.
Epidemic leptospirosis associated with pulmonary hemorrhage Nicaragua, 1995.
J. Infect. Dis.
178:1457-1463[CrossRef][Medline].
|
| 21.
|
Winslow, W. E.,
D. J. Merry,
M. L. Pirc, and P. L. Devine.
1997.
Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection.
J. Clin. Microbiol.
35:1938-1942[Abstract].
|
| 22.
|
Yersin, C.,
P. Bovet,
H. L. Smits, and P. Perolat.
1999.
Field evaluation of a one-step dipstick assay for the diagnosis of human leptospirosis in the Seychelles.
Trop. Med. Int. Health
4:38-45[CrossRef][Medline].
|
Clinical and Diagnostic Laboratory Immunology, March 2001, p. 349-351, Vol. 8, No. 2
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.349-351.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Priya, C. G., Bhavani, K., Rathinam, S. R., Muthukkaruppan, V. R.
(2003). Identification and evaluation of LPS antigen for serodiagnosis of uveitis associated with leptospirosis. J Med Microbiol
52: 667-673
[Abstract]
[Full Text]
-
Bajani, M. D., Ashford, D. A., Bragg, S. L., Woods, C. W., Aye, T., Spiegel, R. A., Plikaytis, B. D., Perkins, B. A., Phelan, M., Levett, P. N., Weyant, R. S.
(2003). Evaluation of Four Commercially Available Rapid Serologic Tests for Diagnosis of Leptospirosis. J. Clin. Microbiol.
41: 803-809
[Abstract]
[Full Text]
-
Effler, P. V., Bogard, A. K., Domen, H. Y., Katz, A. R., Higa, H. Y., Sasaki, D. M.
(2002). Evaluation of Eight Rapid Screening Tests for Acute Leptospirosis in Hawaii. J. Clin. Microbiol.
40: 1464-1469
[Abstract]
[Full Text]
-
Flannery, B., Costa, D., Carvalho, F. P., Guerreiro, H., Matsunaga, J., Da Silva, E. D., Ferreira, A. G. P., Riley, L. W., Reis, M. G., Haake, D. A., Ko, A. I.
(2001). Evaluation of Recombinant Leptospira Antigen-Based Enzyme-Linked Immunosorbent Assays for the Serodiagnosis of Leptospirosis. J. Clin. Microbiol.
39: 3303-3310
[Abstract]
[Full Text]
-
Guerreiro, H., Croda, J., Flannery, B., Mazel, M., Matsunaga, J., Reis, M. G., Levett, P. N., Ko, A. I., Haake, D. A.
(2001). Leptospiral Proteins Recognized during the Humoral Immune Response to Leptospirosis in Humans. Infect. Immun.
69: 4958-4968
[Abstract]
[Full Text]
-
Levett, P. N.
(2001). Leptospirosis. Clin. Microbiol. Rev.
14: 296-326
[Abstract]
[Full Text]